Senate Bill 1768 became law in Florida on July 1, 2025 and amended FS §458.3245 and FS§459.0127, making stem cell therapies, as defined in the statute, available for the following therapeutic indications: orthopedics, wound care, and pain management.
‍‍
The material on this site is intended for general informational and educational purposes only and is not intended to provide medical advice, diagnosis, or treatment recommendations. Pro Biologix doesn’t make any medical claims regarding any of these products. Pro Biologix does not offer medical services to the public and does not endorse or guarantee any third-party products or services referenced. Content may reference investigational biologics or devices not approved by the FDA. If you are a patient please consult your physician for further information. Any mention of product usage are for therapeutic use only in the states of Florida and Utah. Certain information provided herein is intended only for those that may fall under the new Florida stem cell law in effect as of July 1, 2025. Subject to change without notice.